Cohen Barry 5
5 · NOVADEL PHARMA INC · Filed Sep 29, 2004
Insider Transaction Report
Form 5
Cohen Barry
VP, Product & Business Dev
Transactions
- Award
Stock Option (Right to Buy)
2003-05-23+75,000→ 75,000 totalExercise: $2.04Exp: 2008-05-13→ Common Stock (75,000 underlying) - Award
Stock Option (Right to Buy)
2004-02-23+75,000→ 75,000 totalExercise: $1.65From: 2004-02-23Exp: 2009-02-22→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The options vest in three annual installments and upon three performance milestones, as follows: 20,000 options become exercisable on May 13, 2004; 20,000 options become exercisable on May 13, 2005; 20,000 options become exercisable on May 13, 2006; and 5,000 options become exercisable upon the closing of each of the first three licensing agreements by the Filer on behalf of the Issuer.